Biotechnology Novo Nordisk Sets Timeframe For Its Next-Gen Experimental Obesity Drug – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Sarepta Therapeutics’ Next-Gen Duchenne Muscular Therapy Shows Efficacy At Less Frequent Dosing – Sarepta Therapeutics (NASDAQ:SRPT) Read more